Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Regenerative Gel (Emdogain®) for Healing After Wisdom Tooth Extraction

17 luglio 2026 aggiornato da: Ioulianos Apessos, Aristotle University Of Thessaloniki

The Role of Enamel Matrix Derivative in Reducing the Periodontal Defect Distal to the Mandibular Second Molar Following Surgical Extraction of the Third Molar

This study investigates whether the intraoperative application of a specialized regenerative gel (Emdogain®) can improve the periodontal health of the mandibular second molar by preventing or reducing the formation of tissue defects after the surgical removal of an adjacent impacted lower wisdom tooth.

Surgical extraction of a lower wisdom tooth frequently leaves a deep pocket or a permanent hard and/or soft tissue defect on the back side of the neighboring second molar. This defect compromise the surrounding tissues and predispose the healthy second molar to future complications like root caries, dentin hypersensitivity, or localized gum disease. While most existing treatments address these defects after they have formed, this trial evaluates a site-specific preventive approach during the extraction process itself.

The study will involve 70 systemically healthy adults (ages 18-45) requiring surgical removal of a horizontally or mesially oriented impacted lower third molar. Participants will be randomized into two equal groups:

The Test Group: Will receive root conditioning with PrefGel and a single application of Emdogain® gel directly to the root surface and socket immediately after tooth removal.

The Control Group: Will undergo identical surgery but will follow a natural, spontaneous healing process without the application of any biomaterials.

The main objective is to measure changes in Clinical Attachment Level (CAL) at the distal aspects of the second molar using stable vertical anatomical reference points over a 6-month period. The trial will also monitor secondary healing parameters, including probing pocket depths, gum recession, radiographic bone level changes using standardized jigs, postoperative pain, swelling, and early tissue healing dynamics.

Panoramica dello studio

Stato

Reclutamento

Condizioni

Intervento / Trattamento

Descrizione dettagliata

The primary objective of this two-center, parallel-group, randomized clinical trial is to investigate whether the intraoperative application of Enamel Matrix Derivative (EMD) can improve the long-term periodontal health of the mandibular second molar by preventing or minimizing the formation of distal tissue defects following third molar surgery. While the regenerative properties of EMD are well-documented in periodontology, the novelty of this study lies in its prophylactic, site-specific usage at the immediate time of extraction.

Methodology and Standardization

To maximize data reproducibility and minimize measurement errors, the study incorporates the following rigorous standardization protocols:

Anatomical Selection: To control for surgical site variables and baseline defect morphology, inclusion is strictly limited to patients presenting with horizontally or mesially oriented impacted mandibular third molars.

Clinical Measurement Protocol: Clinical parameters are recorded at seven distinct sites around the mandibular second molar: mesio-buccal, mid-buccal, disto-buccal, mesio-lingual, mid-lingual, disto-lingual, and mid-distal. Because the adjacent third molar, the surrounding soft tissue, and limited clinical visibility obscure the distal cementoenamel junction (CEJ) preoperatively, stable and reproducible vertical anatomical landmarks are utilized as reference points for all measurements adjacent to the extraction defect. The disto-buccal site is measured from the distal-buccal cusp tip; the disto-lingual site is measured from the distal-lingual cusp tip; and the mid-distal site is measured from the permanent occlusal (masticatory) surface of the second molar. The remaining four sites (mesio-buccal, mid-buccal, mesio-lingual, and mid-lingual) will be measured from the standard CEJ landmark as usual.

Examiner Calibration: All clinical measurements are performed by a single investigator who undergoes intensive pre-study calibration sessions targeting an intra-examiner intraclass correlation coefficient (ICC) ≥0.85, with scheduled recalibration to prevent measurement drift over time.

Radiographic Calibration and Alignment: To eliminate radiographic distortion and magnification errors, a calibration sphere (metal ball) with a fixed, known diameter of 5 mm is attached to the radiographic setup. Digital image analysis software utilizes the true dimensions of this 5 mm ball to calculate the precise, absolute bone level distances via a standard proportional scale (rule of three). All radiographs are captured using the long-cone paralleling technique, standardized via a customized film-positioning device and repeatable radiographic jigs to ensure identical alignment across all time points.

Study Arms and Follow-up:

Seventy systemically healthy participants (ages 18-45) are randomized to either the Test Arm (debridement, root conditioning with PrefGel, and site-specific application of Emdogain® gel) or the Control Arm (identical surgical protocol allowing for spontaneous healing via a natural blood clot). Both groups receive standardized postoperative pharmacological and oral hygiene care. Early soft-tissue healing and patient-reported outcomes are monitored during the first week, while definitive soft- and hard-tissue periodontal remodeling is evaluated at 6 months postoperatively.

Tipo di studio

Interventistico

Iscrizione (Stimato)

70

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

  • Nome: Ioulianos Dimitrios Apessos, DDS, MD, MSc
  • Numero di telefono: +306937098861
  • Email: idapessos@auth.gr

Luoghi di studio

  • Grecia
      • Thessaloniki, Grecia
        • Reclutamento
        • Aristotle University of Thessaloniki
      • Thessaloniki, Grecia
        • Reclutamento
        • 424 General Military Hospital

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto

Accetta volontari sani

No

Descrizione

Inclusion Criteria:

  • Healthy adult patients aged 18 to 35 years old (ASA I or II).
  • Presence of an asymptomatic, partially or fully impacted mandibular third molar requiring surgical extraction.
  • The third molar impaction must be mesioangular or horizontal, with its crown in direct physical contact with the adjacent second molar, as assessed by a preoperative panoramic radiograph.
  • The adjacent mandibular second molar must be vital, fully erupted, and structurally sound (free of extensive dental caries or prosthetic crowns).
  • Patients must demonstrate an adequate level of overall oral hygiene and gingival health (e.g., Full-Mouth Plaque Index < 20% and Full-Mouth Bleeding Score < 20% following initial prophylaxis and oral hygiene instructions).
  • Willingness to comply with postoperative instructions and adhere to the scheduled follow-up visits.
  • Ability to understand the study procedures and voluntarily sign the informed consent form.

Exclusion Criteria

  • Presence of systemic diseases or conditions that could compromise wound healing or periodontal health (e.g., uncontrolled diabetes mellitus, autoimmune disorders).
  • Current or recent use of medications known to affect bone metabolism or wound healing (e.g., bisphosphonates, long-term systemic corticosteroids, immunosuppressants).
  • History of heavy smoking (e.g., >10 cigarettes per day) or use of smokeless tobacco products.
  • Pregnant or lactating females.
  • Diagnosis of periodontitis (Stage II, III, or IV) affecting the remaining dentition, excluding the localized defect associated with the impacted third molar.
  • Presence of active acute infection (e.g., purulent pericoronitis) or radiolucent pathologic lesions extending beyond the normal follicular space (e.g., dentigerous cysts) that would significantly alter the baseline bony defect morphology.
  • Known allergy or hypersensitivity to any of the medications utilized in the surgical or postoperative protocol (e.g., local anesthetics, prescribed antibiotics, or analgesics).
  • Previous orthodontic treatment utilizing bands on the mandibular second molars that could have affected the periodontal attachment.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Prevenzione
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Doppio

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Emdogain
Participants in this arm will undergo standardized surgical extraction of the impacted mandibular third molar. Following extraction and thorough debridement of the defect, the exposed distal root surface of the adjacent second molar will be conditioned with 24% EDTA (PrefGel). After rinsing, Enamel Matrix Derivative (Emdogain®) will be applied directly to the site prior to standard suturing and primary closure.
Altro: Enamel Matrix Derivative (Emdogain®)
Application of 24% EDTA root conditioning gel (PrefGel) followed by the application of porcine-derived enamel matrix proteins (Emdogain®) to the distal root surface of the mandibular second molar prior to wound closure.
Altri nomi:
  • EMD
  • Enamel Matrix Proteins
  • Amelogenin
  • Straumann Emdogain
Nessun intervento: Spontaneous Healing
Participants in this arm will undergo the identical standardized surgical extraction of the impacted mandibular third molar and thorough debridement of the defect. No root conditioning agents or regenerative biomaterials will be applied. The extraction socket and distal defect will be allowed to heal spontaneously via natural blood clot formation prior to standard suturing and primary closure.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in Clinical Attachment Level (CAL)
Lasso di tempo: Baseline (immediately prior to surgery) and 6 months post-surgery

Clinical Attachment Level (CAL) is a measurement of periodontal health indicating the position of the soft tissue attachment on the tooth root, measured in millimeters (mm) using a calibrated periodontal probe. It will be recorded at seven distinct sites on the mandibular second molar. For the distal sites directly adjacent to the extraction socket, fixed coronal reference points will be used to calculate relative CAL, as the cementoenamel junction (CEJ) is often compromised by the impaction.

For the remaining four sites on the second molar, the standard CEJ will be utilized as the fixed anatomical reference point.

A reduction in the distance from these reference points to the base of the periodontal pocket over time indicates a clinical gain of tissue attachment and successful healing.
Baseline (immediately prior to surgery) and 6 months post-surgery

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in Radiographic Alveolar Bone Level
Lasso di tempo: Baseline (immediate post-operative) and 6 months post-surgery
The vertical distance from the CEJ to the alveolar bone crest at the distal aspect of the mandibular second molar. Measurements will be conducted using standardized intraoral radiographs taken with the parallel cone technique and an individualized occlusal jig to ensure precise spatial reproducibility. The images will be calibrated using radiopaque spheres to account for magnification and will be evaluated by three independent, masked observers.
Baseline (immediate post-operative) and 6 months post-surgery
Change in Probing Pocket Depth (PPD)
Lasso di tempo: Baseline (immediately prior to surgery) and 6 months post-surgery
Distance from the free gingival margin to the base of the periodontal pocket, measured in millimeters (mm) using a calibrated periodontal probe at the seven designated sites around the mandibular second molar (as defined in the primary outcome).
Baseline (immediately prior to surgery) and 6 months post-surgery
Change in Gingival Recession (REC)
Lasso di tempo: Baseline and 6 months post-surgery
Distance from the cementoenamel junction (CEJ) or fixed coronal reference point to the free gingival margin, measured in millimeters (mm) using a calibrated periodontal probe at the seven designated sites around the mandibular second molar.
Baseline and 6 months post-surgery
Change in Bleeding on Probing (BOP)
Lasso di tempo: Baseline and 6 months post-surgery
A dichotomous index (yes/no) assessing the presence or absence of bleeding after periodontal probing at the six sites around the mandibular second molar. It acts as a clinical indicator of localized tissue inflammation.
Baseline and 6 months post-surgery
Change in Plaque Index (PI)
Lasso di tempo: Baseline and 6 months post-surgery
Assessment of the presence or absence of supragingival dental plaque on the surfaces of the mandibular second molar, recorded to monitor the patient's oral hygiene compliance throughout the healing phase.
Baseline and 6 months post-surgery
Postoperative Facial Oedema
Lasso di tempo: Baseline (pre-operative) and 7 days post-surgery
Assessment of postoperative extraoral swelling. This is quantified by measuring the distances between specific anatomical facial landmarks using a flexible measuring tape.
Baseline (pre-operative) and 7 days post-surgery
Postoperative Trismus (Maximum Interincisal Opening)
Lasso di tempo: Baseline (pre-operative) and 7 days post-surgery
Measurement of maximum mouth opening capability to assess postoperative trismus. It is recorded as the maximum vertical distance in millimeters (mm) between the incisal edges of the maxillary and mandibular central incisors.
Baseline (pre-operative) and 7 days post-surgery
Postoperative Pain
Lasso di tempo: Daily for the first 7 days post-surgery
Patient-reported postoperative pain intensity evaluated daily using a Numeric Rating Scale (NRS) ranging from 0 (no pain) to 10 (worst imaginable pain). Additionally, the total number of analgesic tablets consumed by the patient will be recorded via a patient diary.
Daily for the first 7 days post-surgery
Oral Health-Related Quality of Life (OHIP-14)
Lasso di tempo: Baseline (pre-operative), 7 days post-surgery and 6 months post-surgery
Patient-reported outcome assessing the impact of the surgery on daily life using the validated 14-item Oral Health Impact Profile (OHIP-14) questionnaire. Total scores range from 0 to 56, with higher scores indicating a greater negative impact on the patient's quality of life.
Baseline (pre-operative), 7 days post-surgery and 6 months post-surgery
Change in Sleep Quality
Lasso di tempo: Baseline (pre-operative) and 7 days post-surgery
Assessment of postoperative sleep quality and disturbances using the validated Patient-Reported Outcomes Measurement Information System Sleep Disturbance Short Form 8a (PROMIS-SD SF 8a). This instrument specifically evaluates sleep quality over a 7-day recall period. It consists of 8 items, yielding a total score ranging from 8 to 40. Higher scores indicate greater sleep disturbance and a worse postoperative sleep experience.
Baseline (pre-operative) and 7 days post-surgery

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Aristotle University Of Thessaloniki

Collaboratori

Institut Straumann AG

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

9 marzo 2026

Completamento primario (Stimato)

30 settembre 2027

Completamento dello studio (Stimato)

30 ottobre 2027

Date di iscrizione allo studio

Primo inviato

17 luglio 2026

Primo inviato che soddisfa i criteri di controllo qualità

17 luglio 2026

Primo Inserito (Effettivo)

22 luglio 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

22 luglio 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

17 luglio 2026

Ultimo verificato

1 luglio 2026

Maggiori informazioni

Termini relativi a questo studio

Parole chiave

Termini MeSH pertinenti aggiuntivi

Altri numeri di identificazione dello studio

  • 316/18.12.2025.

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

INDECISO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

prodotto fabbricato ed esportato dagli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su Enamel Matrix Derivative (Emdogain®)

Cerca prove simili

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

CROs by country

CROs in Nigeria

Condizioni

Malattie rare

Interventi farmacologici

Supplementi dietetici

Sponsor / Collaboratori

Sedi

Sottoscrivi